Historical record - last NADAC effective date: 1/3/2019

Product Information

OSENI 25-30 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.3977 per EA under NDC 64764025303. Its NADAC has been published 318 times since Dec 18, 2013.

FDA first approved this application on Jan 25, 2013.

OSENI 25-30 MG TABLET

alogliptin and pioglitazone
$12.3977per EA

Strength

25; 30 mg/1; mg/1

NDC

64764025303

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

1/3/2019

Approval Type

New Drug (NDA)

FDA Application

NDA022426

FDA Approved

1/25/2013

On Market Since

1/25/2013

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for OSENI 25-30 MG TABLET has been published 318 times since Dec 18, 2013, and over the history we have for it it has risen 49.9%. The table below summarizes its recorded NADAC range and movement.

Current price$12.3977 per EA
All-time high$12.3977 (Jan 15, 2020)
All-time low$8.2705 (Dec 18, 2013)
Median price$11.8059
Average price$11.2704
Largest weekly change+9.9% (Aug 12, 2015)
Weeks tracked318
Tracking sinceDec 18, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+49.9%

Last surveyed Jan 15, 2020 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alogliptin and pioglitazone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OSENI 25-30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OSENI 25-30 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.3977 per EA (NDC 64764025303), effective Jan 15, 2020.

How has the price of OSENI 25-30 MG TABLET changed over time?

Over the history we have for it, the NADAC for OSENI 25-30 MG TABLET has risen 49.9%. It has been tracked across 318 weekly CMS publications since Dec 18, 2013.

What are the highest and lowest recorded NADAC prices for OSENI 25-30 MG TABLET?

Since Dec 18, 2013, the NADAC for OSENI 25-30 MG TABLET has ranged from a low of $8.2705 (Dec 18, 2013) to a high of $12.3977 (Jan 15, 2020), with a median of $11.8059 per EA.

Are there cheaper alternatives to OSENI 25-30 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of OSENI 25-30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OSENI 25-30 MG TABLET?

OSENI 25-30 MG TABLET (NDC 64764025303) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.